1 alpha,24-dihydroxycholecalciferol,
1 alpha,24-dihydroxyvitamin D3,
1 alpha,24-dihydroxyvitamin D3, (1alpha,3beta,5Z,7E,24R)-isomer,
1 alpha,24-dihydroxyvitamin D3, (1alpha,3beta,5Z,7E,24S)-isomer,
1,24-dihydroxycholecalciferol,
1,24-dihydroxyvitamin D3,
Curatoderm,
PRI-2191,
Tacalcitol,
tacalcitol,
57333-96-7,
Curatoderm,
Bonalfa,
UNII-C2W72OJ5ZU,
TV-02H,
TV-02,
PRI 2191,
1-alpha,24(R)-Dihydroxyvitamin D3,
C2W72OJ5ZU,
1alpha,24(R)-Dihydroxyvitamin D3,
Tacalcitolum [INN-Latin],
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol,
CCRIS 4211,
Tacalcitolum,
TV 02,
(24R)-1alpha,24-dihydroxyvitamin D3 / (24R)-1alpha,24-dihydroxycholecalciferol,
(5Z,7E)-(1S,3R,24R)-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol,
Bonalfa (TN),
Tacalcitol [INN:BAN:JAN],
Vellutan,
Apsor,
(1-alpha,3-beta,5Z,7E,24R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol,
Tacalcitol (INN),
PubChem18827,
tv02,
AC1NR2WO,
1alpha,24(OH)2D3,
SCHEMBL3945,
TV-02HS,
1a,24-Dihydroxycholecalciferol,
GTPL2780,
1,24(R)-Dihydroxyvitamin D3,
CHEMBL2105611,
Tacalcitol, >=99% (HPLC),
(+)-(5Z,7E,24R)-9,10-Secocholesta-5,7,10(19)-triene-1alpha,3beta,24-triol,
9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol, (1-alpha,3-beta,5Z,7E,24R)-,
BJYLYJCXYAMOFT-RSFVBTMBSA-N,
PRI-2191,
ZINC4474668,
4077AH,
BDBM50441892,
LMST03020256,
AKOS024458008,
CS-0391,
HY-32337,
SC-77203,
C12919,
D08554,
W-5147,
333T967,
1,24(R)-Dihydroxyvitamin D3;1.alpha.,24R-Dihydroxyvitamin D3,
(1?,3?,5Z,7E,24R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol,
(1R,3S,Z)-5-(2-((1R,3aS,7aR,E)-1-((2R,5R)-5-hydroxy-6-methylheptan-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol,
Tacalcitol [INN:JAN],
D08SVH,
1,24-Dihydroxyvitamin D3,
C27H44O3,
C27-H44-O3,
CB10272,
CID5283734,
CS-O-02486,
1-alpha,24(R)-dihydroxycholecalciferol,
A3848,
1,24(R)-Dihydroxyvitamin D3; (1a,3b,5Z,7E,24R)-9,10-Secocholesta-5,7,10(19)-triene-1,3,24-triol,